Specifically, 20% of the malignancies that emerged in Mdm2+/−Arf+/−p53+/− mice were carcinomas, whereas only 6% were carcinomas in Mdm2+/+Arf+/−p53+/− mice. Here, CDKN2A is linked to carcinoma.